Glucagon-Like Peptide-1 Receptor Agonists and Sodium Glucose Cotransporter-2 Inhibitors and Cardiorespiratory Fitness Interaction

D Ni, P Kokkinos, ES Nylen - Military Medicine, 2024 - academic.oup.com
Introduction Cardiorespiratory fitness (CRF) is a stronger predictor of mortality than
traditional risk factors and is a neglected vital sign of health. Enhanced fitness is a …

Dual glucagon‐like peptide‐1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity

R Golubic, J Kennet, V Parker… - Diabetes, Obesity …, 2024 - Wiley Online Library
Aims To establish which components of energy balance mediate the clinically significant
weight loss demonstrated with use of cotadutide, a glucagon‐like peptide‐1 (GLP …

The American Academy of Pediatrics Obesity guidelines—a critical appraisal

N Skolnik - JAMA pediatrics, 2023 - jamanetwork.com
Adolescent obesity is a critical public health issue that affects 26% of adolescents. 1
Guidelines recently published by the American Academy of Pediatrics (AAP) provide a much …

Use of novel glucose-lowering therapies in novel populations with type 2 diabetes

E Ahmad - 2024 - figshare.le.ac.uk
The phenotype of T2D is rapidly evolving due to increasingly sedentary lifestyles and
unhealthy eating behaviours. Many individuals are diagnosed with T2D at a younger age …

Preservation of healthy lean body mass and function during weight loss

T Wilkinson, D Papamargaritis, J King, J Sargeant… - 2024 - figshare.le.ac.uk
Sustainable treatments for obesity are needed and novel pharmacotherapies that aid weight
loss appear promising. In their proposed agenda, Pinkney and Tarrant1 highlight additional …